How Is Danaher Corporation’s Stock Performance Compared to other Health Care Stocks?

Headquartered in Washington, D.C., Danaher Corporation (DHR) is a global science and technology powerhouse focused on biotechnology, life sciences, and diagnostics. With a market capitalization of nearly $149 billion, it sits in the “large-cap” territory, a space reserved for companies valued above $10 billion. 

This scale gives Danaher the muscle to build bioprocessing systems, precision laboratory instruments, genomic technologies, and clinical diagnostic platforms that anchor drug development, scientific research, and patient care across hospitals, laboratories, and biopharma facilities worldwide.